The NEW ENGLAND JOURNAL of MEDICIN E tainedat prespecified intervals. Theuse ofprotocols nized24,25 that in follow-up visits in observational thatare not well standardized in the assessment of studies, the proportion ofpatients with adequately the office blood pressure may lead to a high degree controlled blood pressure is still far from optimal: of variance in this measure, particularly among In this sense, our study is a more accurate reflection treated patients such aS those in our study ofeveryday practice than are studies in which blood Another weakness of routine blood-pressure pressure is better controlled_ measurement that may have influenced our results Our study shows that 24-hour ambulatory blood is that the effects of peakand trough ef pressure predicts the risk of cardiovascular events fects) may have had a greater influence on the vari- even after adjustment for classic risk factors includ- ance in office readings than on thatin 24-houram- office blood pressure The next step will be to bulatory readings. Our study was not designed to determine the role ofambulatory blood-pressure address the effects ofindividual drugs or classes of monitoring in clinical practice and whether the therefore; patients were allowed to take all cost-benefit ratio favors adding such monitoring classes of which were administered at the to the standard care of 'patients with treated hy- discretion of their physicians. pertension.26,27 Patients enrolled in our study were not optimal- Supported by the Flemish Science Foundation (Fonds voor Weten- schappelijk Onderzoek-Vlaanderen) , the University of Ghent; the ly treated, asjudged by their office readings at visit University Hospital of Ghent; AstraZeneca, Boehringer Ingelheim_ 3 (only 25 percenthad an office systolic blood pres- Roche, Pfizer; Servier-Eutherapie Benelux, the Rotary Club Ghent; sure below 140 mm Hg). Yearly follow-up visits and the Stichting Gezondheidszorg Nollet: We are indebted to Mrs. Linda Packet for her help in administer- failed to show improvement (data not shown) , al- ing the study and her help in the preparation ofthe manuscript; and though participating physicians were continuously to Mrs. Gerda Bollaert and Mrs. Marleen Van Hecke for their logistic asked to adhere more closely to the target office help during the study: blood pressure of 140/90 mm It is well recog- APPENDIX The Office versus Ambulatory Blood Pressure (OvA) study was conducted under the auspices ofthe European Society of Hypertension, the European Society of Cardiology and the Belgian Hypertension Committee The following investigators were responsible for the coordina- tion ofthe participating clinicians (an asterisk denotes deceased): Trial coordinator-_ D. Clement; National coordinators- Caparovski* (Re- public of Macedonia) , M. Carrageta (Portugal), R Cifkova (Czech Republic), J.P Degaute (Belgium)  de Leeuw (the Netherlands), M. inski (Poland) , J.M: Mallion (France) , E: O'Brien (Ireland) , D Palatini (Italy) , J.L. Rodicio (Spain); Coordinators of Belgian general practices Beys, K Bruyneel, M: D. De Clercq, D. Defrance; J. Deheneffe; Y Deheneffe;, D De Jaegher; Friart; L. Geutjens, M. Gysbrechts, Herman, M. Kahan, A. Kassab_ L. Labaki, P Lafontaine; J. Lalmand, H. Lesseliers, D Mertens, E. Mievis, E. Robbens R Six, C. Stevens, Streulens, J. Thoeng, P Timmermans_ P Van Der Niepen, A. Van Dorpe, E: Van Houwe, P Van Iseghem, D Vermeersch; Protocol Committee - DL. Clement; A Coats, J. Conway; G. Mancia, O Brien; End-Point Committee P de Leeuw, R Fagard (chairs), D. Duprez and P Gheer- aert (associate members); Publication Committee- D.L. Clement; M De Buyzere; P deLeeuw, R Fagard, E. O Brien; Data Monitoring Committee D. De Bacquer (statistical analysis) , M. De Buyzere, L. Missault; L. Packet; Ethics Committee W. Birkenhager; M. Bogaert; A. Zanchetti. In addition; the following investigators participated in the study: University Hospital Leuven, Campus Gasthuisberg, Leuven, Belgium Fagard, J. Staessen; St: Jozefziekenhuis, Turnhout, Belgium I. Bekaert; Centre Hospitalier Universitaire Tivoli, La Louviere, Belgium P Dupont; University Hospital, Ghent; Belgium - D. Duprez; Universitaire Instelling Antwerpen, Antwerp, Belgium -~ J. Denekens_ E Rademakers; Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium R Lins; Hopital Saint Luc, Brussels, Belgium -_J.E De Plaen; Private cardiologists and general practition- ers Belgium -_ H: Antonneau, L. Arcache, D. Barina, S. Bartholomeeusen, M. Barvais, I Bayon, A. Bellucci; L. Berghmans,A Berghs, Bernard, K  Bertels, G. Binet; L. Bleyen, J. Bogaert, E Bolly, L Bonami, D. Bonhomme, M. Bonhomme, A. Boogaerts, H. Boufessile, ) Boxus, B. Brichard L. Bril, M. Brinker; C. Busellato, J. Busschaert; J. Cambier; P Capiau; A. Carlier; J. Caudelier; P Cayman, H. Cerfon- taine, P: Ceurvelts P Chapelle, G. Charlier; G. Clerinx; E. Cloot-Snyders, S. Coene; A. Collin, D. Content; M. Content; M: Coopmans, Cornelis, J.M. Crespeigne; MJ. Cuvelier; G. De Bilderling, R De J.P De Corte, W. De Geyseleer; E De Greef;, F De Greve, R De Jongh, M. De Kimpe, A. De Leeuw; L. De Lille, B. De Man, D. De Munck; J. De Pourcq, H: De Ridder; M: De Roeck; M. De Ruyttere, H: De Schryver; A. De Vlieger; L De Voecht; J. De J. Dewachter; H. De Wit; P De Witte, A. Decerf; J. Declerck, E. Deconinck; [. Deeren _ Dejaegher; A. Delhauteur; D. Delsate, R Demets _ J. Dens, M. Derycke, M. Deschamps  P Descheemaeker; G. D'Hanis, P D'Hanis, M_ D'Hollander; W. D'Hooge, P Dieleman, R Diels, D. Di Mattia, G. Economou, A. Elouehabi, M: Elsen, E. Ercken_ F Evrard_ Fellah, L. Ferrant; AC. Feye; D. Flahou; R Follet; I. Geenen, R Gevaert; L. Gielen L. Gillemon, E Goethals, K. Goethals, J.C. Goffin, V: Goossens, D Grand, G. Gras_ A. Grimee, J. Grosjean, R Haardt; I Haumont, J. Hellebaut;, K  Hendrickx; W Hendrickx; W Hens, C. Ho Van, M: Hubert; L. Ieven, A Jadin, P Jaspers, M. Joly, A Jorion_ B.Jortay, P Joskin, G.Jouret; P Kerckhoven, L. Kestens, Keutgen, G_ Lam- brechts, H_ Lammers  Laskar; A Lecocq, C. Ledoux, J. Ledune; @ Leemans, A. Lefebvre; C. Lefebvre, D Lenaerts, D Lesage, R Lietaer; L. Louette; J. Luyts, R Maes, M: Maex_ Manceaux-Thirion; G. Marco, J. Marquet-Lochegnies, Martens, J. Masureel, Maudens, R Maudens, J.P Meurant; E_ Meys, A Migeotte, A Mignot; M Minnart; J. Moerman, JP Monette, A. Monoyer; Moonen_ Y Moons, Moreels, J.E Mouvet; N. Neiman, J. Neven, E Nollomont; J. Nuyten; W: Onsea, M: Pareit; E. Peeters, G. Peeters, L. Peremans, J.L. Perilleux; Phang, D. Plessers, M. Poot; D Quertinier; J D Ralet; M. Rase, J.C. Reichling, R Remmen, P Robert; J.P Rochet; E Roelandts, M. Roland, J.Y Rousseau; M: Saey, E Sas, D. Scheveneels, L. Schillemans_ E. Schreurs B. Seront; J. Sette; M. Simons, P Simons, @ Sisani, J. Smekens, J.E Soupart; J.E Spiertz, A. Spilsteyns_ E Spirlet; J. Sprenghers, J. Staelens, D. Strens, H: Stuer; C. Swinne; D Taes, M: Talloen, M Temmer- man_ Thibaut; D Thiry, HT Duy; Y Urbain, P Van Berkel, L. Van Boxelaer; J. Van Brabant; B. Van Damme; I: Van De Velde; A Van De Weyer; E Van Den Broek; G. Van Den Bussche; L Van Den Eeckhout; W: Van Den Eede, B. Van den Eynden, H: Van Der Veken, W 2414 N ENGL ) MED 348,24 WWW.NEJM.ORG JUNE 12, 2003 The New England Journal of Medicine Downloaded from nejm org at MONTEFIORE HOSP & MED CTR on June 29, 2023. For personal use only. No other uses without permission Copyright 2003 Massachusetts Medical Society. All rights reserved. drugs' (e.g;, ing = drugs; drugs, Hg: Lap- Bury, Bruyn, Vos, Fabry; Tran, Tran